Percheron Therapeutics LimitedASX: PER

First Patient Dosed in Phase II DMD Clinical Trial

Aug 29, 2018 at 12:59 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment